Biphasic Effects of Acute Alcohol Intoxication on Bystander Intervention
Launched by GEORGIA STATE UNIVERSITY · Jan 18, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how alcohol affects people's willingness to intervene in situations of sexual violence, particularly looking at how this may differ between men and women. The researchers want to understand if being intoxicated changes how likely someone is to help, and if individuals with more positive attitudes towards helping others respond differently than those with less positive attitudes. Participants will be asked to imagine themselves in a risky situation while consuming either an alcoholic drink or a non-alcoholic control drink.
To join the study, participants must be between the ages of 21 and 30 and have consumed a significant amount of alcohol on at least three occasions in the past year. However, people who are currently in treatment for alcohol issues, pregnant, or have certain medical conditions that don't allow alcohol consumption cannot participate. Those who take part will be randomly given either an alcoholic or non-alcoholic drink and will engage in a scenario designed to assess their reactions and intentions regarding helping in a potential sexual violence situation. This study aims to gather important information that could help improve bystander intervention strategies in real-life situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 21 and 30
- • Report that on at least 3 days in the past year they have consumed an alcohol quantity on a single occasion that was equal or greater to the dose administered in the lab
- Exclusion Criteria:
- • Currently seeking treatment or in recovery for an alcohol or substance use disorder
- • A medical condition or medication use in which alcohol consumption is medically contraindicated
- • Pregnant, nursing, or has engaged in sexual intercourse without effective contraception in the past two weeks
- • If the participant is less than six feet tall and weighs over 250 pounds or is over six feet tall and weighs over 300 pounds
About Georgia State University
Georgia State University is a leading research institution dedicated to advancing knowledge through innovative clinical trials and studies. With a strong emphasis on public health and community well-being, the university leverages its multidisciplinary expertise to conduct rigorous research aimed at addressing pressing health challenges. As a sponsor of clinical trials, Georgia State University fosters collaboration among researchers, healthcare professionals, and community partners, ensuring ethical standards and scientific integrity are upheld throughout the research process. Its commitment to translating research findings into real-world applications positions the university as a key contributor to the advancement of medical science and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Ruschelle M Leone, PhD
Principal Investigator
Georgia State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials